Covered recipient · General Payments record
KATRINA ADELE ROMEO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$741.60
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $514.37 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $220.78 | 6 |
| VIVUS LLC | $92.55 | 4 |
| Novo Nordisk AS | $92.49 | 4 |
| INTRA-SANA LABORATORIES | $92.26 | 3 |
| Currax Pharmaceuticals LLC | $16.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Currax Pharmaceuticals LLC | $16.29 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089522778 | CMS |
| Intra-Sana Laboratories | $50.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138622336 | CMS |
| Intra-Sana Laboratories | $21.13 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138622338 | CMS |
| Intra-Sana Laboratories | $21.13 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138622340 | CMS |
| Lilly USA, LLC | $19.48 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135747360 | CMS |
| Lilly USA, LLC | $21.08 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135747362 | CMS |
| Lilly USA, LLC | $20.87 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135787634 | CMS |
| Lilly USA, LLC | $117.76 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135787636 | CMS |
| Lilly USA, LLC | $20.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135734597 | CMS |
| Lilly USA, LLC | $20.79 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135747364 | CMS |
| Novo Nordisk Inc | $22.72 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100308811 | CMS |
| Novo Nordisk Inc | $22.70 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100605836 | CMS |
| Novo Nordisk Inc | $22.91 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284108 | CMS |
| Novo Nordisk Inc | $24.16 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269248 | CMS |
| VIVUS LLC | $21.27 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421013 | CMS |
| VIVUS LLC | $24.55 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421015 | CMS |
| VIVUS LLC | $23.54 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421017 | CMS |
| VIVUS LLC | $23.19 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.